KRAS gene amplification to define a distinct molecular subgroup of gastroesophageal adenocarcinoma.

作者
Les Henderson,Peng Xu,Emily O’Day,Fabiola Cecchi,Adele R. Blackler,Wei‐Li Liao,Todd Hembrough,Daniel V.T. Catenacci
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:34 (4_suppl): 74-74
标识
DOI:10.1200/jco.2016.34.4_suppl.74
摘要

74 Background: KRAS mutation is rare ( < 5%) in gastroesophageal cancer (GEC). However, the incidence of KRAS gene amplification (amp+), consequent protein levels, and prognostic and/or therapeutic implications are unknown. Methods: 410 GEC samples and 30 cell lines were assessed for KRAS gene copy number (GCN) by fluorescence in situ hybridization (FISH) (n = 90), Kras expression by selected reaction monitoring mass spectrometry (Kras-SRM-MS) (n = 393), and Kras-SRM level evaluated for correlation with KRAS amp+ status (n = 73). Survival analysis was performed comparing KRAS amp+ versus non-amp+ patients. When possible, concurrent 315 gene next-generation sequencing was also performed. Four KRAS-amplified xenograft lines (CAT-2,12,14,15) were established from malignant effusions. Tumorigenic activity of KRAS amp+ lines (CAT lines, MKN-1) were assessed using MTT and soft agar assays in vitro and subcutaneous xenograft models, compared to non-amp+ lines. Inhibitory assays were performed using KRAS siRNA and CRIPSR, and commercial inhibitors targeting downstream effectors MEK and/or PIK3CA. Results: KRAS FISH revealed clustered gene amp+ in 28.9% (26/90); these patients had worse prognosis than non-amp+ patients. GCN significantly correlated with Kras expression. All KRAS amp+ cell lines significantly overexpressed Kras protein and were tumorigenic in xenograft subcutaneous models. KRAS siRNA and KRAS CRISPR of KRAS amp+ cell lines demonstrated inhibition in MTT viability and soft agar assays, compared to appropriate controls, and demonstrated significant and durable xenograft growth reduction. Conversely, inhibition using MEK and/or PI3K inhibitors demonstrated only transient growth reduction in vivo. Conclusions: KRAS gene amp+ was observed in a large subset (26%) of GEC patients, which correlated with extreme expression by mass spectrometry. Established xenograft lines serve as models to investigate therapeutic strategies for KRAS amp+ patients. Inhibition using MEK/PIK3CA inhibitors provided transient benefit for KRAS amp+ tumors while durable inhibition was observed with Kras protein knockdown, suggesting potential benefit from novel siRNA therapeutics currently in development.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我的zhu会费完成签到,获得积分20
刚刚
昵昵昵昵昵完成签到 ,获得积分10
刚刚
Dr_nie完成签到,获得积分10
1秒前
1秒前
bin完成签到,获得积分10
1秒前
正直的绮南完成签到 ,获得积分10
2秒前
多读点文献完成签到 ,获得积分10
2秒前
shuke发布了新的文献求助10
3秒前
结实成仁完成签到 ,获得积分10
3秒前
一心扑在搞学术完成签到,获得积分10
4秒前
Chen完成签到 ,获得积分10
4秒前
4秒前
Nariy完成签到,获得积分10
5秒前
零一完成签到,获得积分10
5秒前
伶俐微笑完成签到,获得积分10
5秒前
Judy完成签到 ,获得积分10
6秒前
黄豆酱子完成签到,获得积分20
6秒前
XIGRAY完成签到,获得积分10
6秒前
晴天发布了新的文献求助10
7秒前
7秒前
Echo完成签到,获得积分10
7秒前
7秒前
sometimesawake完成签到,获得积分10
8秒前
8秒前
8秒前
8秒前
小木虫完成签到,获得积分10
8秒前
ll完成签到,获得积分20
8秒前
Seer完成签到,获得积分10
8秒前
迷雾完成签到,获得积分10
9秒前
solar完成签到,获得积分10
10秒前
秋风的应助被NiaoJiang采纳,获得10
10秒前
Estelle完成签到,获得积分10
11秒前
11秒前
gina完成签到,获得积分10
11秒前
曾sir完成签到,获得积分10
11秒前
独特觅翠完成签到,获得积分10
11秒前
虚幻曼冬完成签到,获得积分10
12秒前
陈雨柏发布了新的文献求助10
12秒前
369ninja发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039